Olanrewaju Sanusi is an experienced business leader with over thirty years’ experience in the Financial, Telecoms, Healthcare, Quick Service Restaurant and Agricultural sectors. She is a strategic finance executive who works collaboratively to develop and implement core business strategies. She has expertise in financial strategy, mergers & acquisitions,
corporate finance, restructuring, business and technology transformation, operations, governance, risk management, fund raising and resource & treasury allocation.
She has over twenty-one years’ experience operating at executive board level having served as Finance Director at various multinational and private equity backed companies including IFC (part of World Bank Group), SwissRe, Investment Fund for Health in Africa (IFHA), Ceil Healthcare Africa (CHA), Helios Investment Partners UK, DPI Capital UK and Satya Capital UK.
She was previously the Group CFO and Executive Director of Hygeia Nigeria Limited – a leading private healthcare integrated hospital and health insurance group and CFO of Helios Towers Nigeria (a colocation company owned by Helios Investment Partners UK). She also previously served as Finance Director in charge of Finance & Supply Chain for Pfizer, the global multinational pharmaceutical company, in charge of 16 countries including Nigeria, Ghana, Kenya and other East African countries. During the period of her tenor, Lanre served as Interim CEO for Pfizer Specialties Limited (Nigeria & East Africa Region), Hygeia HMO Limited and Hygeia Nigeria Limited.
Lanre has extensive experience in finance (including finance operations, budgeting & planning, treasury, supply chain, tax & compliance, and risk management), in addition to being part of the executive leadership driving the strategic direction. She has led several billion naira international and local fund (both debt and equity) raising efforts to execute very successful and transformational expansion plans.
Lanre is a Fellow of the Institute of Chartered Accountants of Nigeria, a Graduate Member of the Chartered Institute of Stockbrokers (where she a 1st prize winner for all 3 stages of professional exams) and has an MBA from Imperial College, University of London (specializing in new ventures).